• Bio-Techne held a special shareholder meeting today to vote on its merger agreement with Merck KGaA, Darmstadt, Germany.
• Shareholders approved and adopted the definitive merger agreement; the acquisition itself has not yet closed.
• Closing remains targeted for late 2026 or early 2027, subject to remaining customary conditions and regulatory clearances.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609230920PR_NEWS_USPR_____CG54646) on September 23, 2026, and is solely responsible for the information contained therein.